Park Edge Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Park Edge Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$829K	Hold	14,381	–	–	0.17%	87
2026 Q1	$872K	Sell	14,381 -19	-0.1%	-$1.11K	0.2%	77
2025 Q4	$777K	Hold	14,400	–	–	0.18%	85
2025 Q3	$649K	Sell	14,400 -377	-3%	-$17.6K	0.15%	86
2025 Q2	$684K	Hold	14,777	–	–	0.18%	83
2025 Q1	$901K	Hold	14,777	–	–	0.25%	71
2024 Q4	$836K	Hold	14,777	–	–	0.24%	69
2024 Q3	$765K	Sell	14,777 -600	-4%	-$28.1K	0.22%	79
2024 Q2	$639K	Sell	15,377 -500	-3%	-$22.4K	0.2%	80
2024 Q1	$861K	Sell	15,877 -826	-5%	-$42.1K	0.24%	59
2023 Q4	$857K	Hold	16,703	–	–	0.3%	46
2023 Q3	$969K	Hold	16,703	–	–	0.35%	32
2023 Q2	$1.07M	Sell	16,703 -598	-3%	-$40.1K	0.36%	26
2023 Q1	$1.2M	Sell	17,301 -210	-1%	-$14.8K	0.46%	22
2022 Q4	$1.26M	Buy	+17,511	New	+$1.32M	0.55%	23

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Park Edge Advisors's BMY Position: Q2 2026 in Review

Park Edge Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 14,381 shares worth $829K. The position accounts for 0.17% of the portfolio, ranked #87.

Park Edge Advisors first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.26M in Q4 2022. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Park Edge Advisors held 14,381 shares of Bristol-Myers Squibb worth $829K as of Q2 2026.
Park Edge Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.17% of Park Edge Advisors's portfolio in Q2 2026, its #87 holding.
Park Edge Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
Park Edge Advisors's Bristol-Myers Squibb position peaked at $1.26M in Q4 2022.
440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.